PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMaastricht University Medical Center
About this trial
Pregnancy is considered a cardiovascular (CV) stress test, and complicated pregnancies are associated with an increased risk for cardiovascular disease (CVD) later in life. Moreover, it is known that often the pregnancy induced CV adaptation does not resolve completely after a short postpartum (PP) period and it is not clear whether these induced changes will resolve over a longer period of time (i.e. in the upcoming months/years after delivery).
Understanding the cardiac adaptation during pregnancy and the reversal process in the postpartum period, as well as the factors that influence this these processes, may provide us not only insight in this mechanism, but may help us in identifying factors that may be target points for modification.
Eligibility criteria
Qualifiers
Women aged ≥ 18 years
Controls: Women with an uncomplicated pregnancy at the moment of inclusion (i.e no foetal or maternal placental complications, such as pregnancy induced hypertension, preeclampsia or HELLP-syndrome, or small for gestational birth infancies)
Cases: Women diagnosed with a preeclamptic pregnancy at the moment of inclusion
Disqualifiers
Allergy or intolerance to glyceryl trinitrate, betablockers or iodinated contrast media.
Controls: Pre-existing chronic hypertension treated with antihypertensive medication or autoimmune disorder.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
226 Participants
are grouped into 6 trial groups6
Trial groupsSee each trial group below.
Sponsors and collaborators
Source ClinicalTrials.gov